Tags: Chronic Pain | migraine | drug | succeeds | late-stage | study

Migraine Drug Succeeds in Late-Stage Study

Image: Migraine Drug Succeeds in Late-Stage Study
(Copyright iStock)

Wednesday, 31 May 2017 08:45 AM

Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine met the main goal in a late-stage study.

Patients treated with the drug, fremanezumab, experienced a statistically significant reduction in the number of monthly headache days over the 12-week period for both monthly and quarterly dosing regimens, the company said.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine met the main goal in a late-stage study.Patients treated with the drug, fremanezumab, experienced a statistically significant reduction in the number of monthly headache days over...
migraine, drug, succeeds, late-stage, study
53
2017-45-31
Wednesday, 31 May 2017 08:45 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved